Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 31, 2026 17:23 ET | Source: BCC Research LLC

Global Ion Exchange Materials Market to Reach $5.9 Billion by 2030, Driven by Green Hydrogen, Water Treatment Standards and Energy Security Demands

The study highlights expanding applications in water treatment, pharmaceuticals, and chemical processing as key drivers of global market growth.
March 25, 2026 12:15 ET | Source: Io Therapeutics, Inc.

Io Therapeutics, Inc. announces publication in Scientific Reports – Nature, of studies showing synergistic efficacy of its RXR agonist IRX4204 with the standard of care drug lenalidomide against multiple myeloma.

The Io Therapeutics, Inc. clinical stage anti-cancer RXR agonist compound demonstrated efficacy in models of human multiple myeloma.
March 25, 2026 11:10 ET | Source: GH Research PLC

GH Research Announces Publication of Phase 2b Results for Mebufotenin (GH001) in JAMA Psychiatry and Reports New Finding of Severity-Independent Efficacy in TRD

Phase 2b results for GH001 in TRD now published and peer-reviewed in JAMA Psychiatry New peer-reviewed article in forthcoming issue of Psychopharmacology Bulletin demonstrates that GH001 efficacy is...
March 23, 2026 09:00 ET | Source: China SXT Pharmaceuticals, Inc.

China SXT Pharmaceuticals, Inc. Announces Share Re-classification

TAIZHOU, China, March 23, 2026 (GLOBE NEWSWIRE) -- China SXT Pharmaceutics, Inc. (Nasdaq: SXTC) (the “Company” or “SXTC”), a specialty pharmaceutical company focusing on the research, development,...
March 19, 2026 16:05 ET | Source: Assembly Biosciences, Inc.

Assembly Biosciences Reports Year-End 2025 Financial Results and Recent Highlights

– Successfully licensed helicase-primase inhibitor program for recurrent genital herpes to Gilead, including candidates ABI-5366 and ABI-1179, following positive Phase 1b interim data; development...
March 18, 2026 13:41 ET | Source: Faruqi & Faruqi LLP

KD CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds Kyndryl Investors of Securities Class Action Deadline on April 13, 2026

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Kyndryl To Contact Him Directly To Discuss Their Options If you purchased or...
March 18, 2026 08:00 ET | Source: Corbus Pharmaceuticals Holdings, Inc.

Corbus Pharmaceuticals to Participate in the BMO 2026 Metabolic Health Summit

NORWOOD, Mass., March 18, 2026 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings Inc. (NASDAQ: CRBP), a clinical-stage company focused promising new therapies in oncology and obesity, today...
March 18, 2026 07:00 ET | Source: Nutriband Inc.

Nutriband AI Kinesiology Tapes approved for Distribution and Sale in Costa Rica

Approval in Costa Rica for Kinesiology Tape Products
March 13, 2026 12:38 ET | Source: Research and Markets

Sevenfact Market Research Report 2026: Epidemiology, Pipeline Analysis, Trends, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

Dublin, March 13, 2026 (GLOBE NEWSWIRE) -- The "Sevenfact Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" has been added to ResearchAndMarkets.com's offering. ...
March 13, 2026 12:35 ET | Source: Research and Markets

Roctavian (BioMarin Pharmaceutical) Market Research Report 2026: Epidemiology, Pipeline Analysis, Trends, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

Dublin, March 13, 2026 (GLOBE NEWSWIRE) -- The "Roctavian Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" has been added to ResearchAndMarkets.com's offering. ...